Author

Colin A. Lester

Observed name: Colin A Lester

Institution: Vaxart (United States)

Observed institutions: Vaxart (United States), Stanford Medicine, Stanford University

ORCID: 0009-0001-2639-5990

Observed ORCID: 0009-0001-2639-5990

OpenAlex ID: A5087295376

An oral norovirus vaccine tablet was safe and elicited mucosal immunity in older adults in a phase 1b clinical trial

2025 · Becca A. Flitter, Susan N. Greco, et al. · Science Translational Medicine · 20

Hyaluronan synthesis inhibition impairs antigen presentation and delays transplantation rejection

2020 · Payton L. Marshall, Nadine Nagy, et al. · Matrix Biology · 16

Mucosal Immunization of Cynomolgus Macaques with Adenoviral Vector Vaccine Elicits Neutralizing Nasal and Serum Antibody to Several SARS-CoV-2 Variants

2022 · Becca A. Flitter, Colin A. Lester, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 5

Transfer of breast milk IgA to infants after oral bivalent norovirus vaccination of post-partum women

2026 · Molly R. Braun, Lam-Quynh Nguyen, et al. · npj Vaccines · 2

A Next-Generation Adenoviral Vaccine Elicits Mucosal and Systemic Immunogenicity and Reduces Viral Shedding after SARS-CoV-2 Challenge in Nonhuman Primates

2024 · Sarah N. Tedjakusuma, Colin A. Lester, et al. · Vaccines · 2

Adenoviral-Based Vaccine Elicits Robust Systemic and Mucosal Cross-Reactive Responses in African Green Monkeys and Reduces Shedding after SARS-CoV-2 Challenge

2022 · Sarah N. Tedjakusuma, Colin A. Lester, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2

175. An Open-Label Phase 1 Clinical Trial Demonstrating Improved Immune Responses to Norovirus Strains GI.1 and GII.4 from a Second Generation Oral Bivalent Vaccine Candidate

2026 · Nicholas J Bennett, Becca A Flitter, et al. · Open Forum Infectious Diseases

594. A Phase I, Multicenter, Randomized, Double-blind, Placebo-controlled Single Dose, Dose-ranging Study to Evaluate the Safety, Tolerability, and Immunogenicity of Orally Administered Bivalent GI.1/GII.4 Norovirus Vaccine in Healthy Lactating Females ≥ 18 years Old and Their Breast-feeding Infants

2025 · Lam Nguyen, Susan Greco, et al. · Open Forum Infectious Diseases

1960. Mucosal rAd5 Immunization against SARS-CoV-2 Spike Elicits Cross-Reactive Nasal and Serum Neutralizing Antibodies and Protects Against Beta Variant Challenge in African Green Monkeys

2022 · Becca A Flitter, Sarah N Tedjakusuma, et al. · Open Forum Infectious Diseases

Works count: 9

Citation count: 47

H-index: 3

I10-index: 2